BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 21480373)

  • 1. Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders.
    King AE; Mintz J; Royall DR
    Mov Disord; 2011 Jun; 26(7):1218-24. PubMed ID: 21480373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 123I-metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders.
    Rascol O; Schelosky L
    Mov Disord; 2009; 24 Suppl 2():S732-41. PubMed ID: 19877202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of 123I-metaiodobenzylguanidine myocardial scintigraphy in the diagnosis of Lewy body disease in patients with dementia in a memory clinic.
    Hanyu H; Shimizu S; Hirao K; Sakurai H; Iwamoto T; Chikamori T; Hida S; Yamashina A; Koizumi K; Abe K
    Dement Geriatr Cogn Disord; 2006; 22(5-6):379-84. PubMed ID: 16960446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 123I-metaiodobenzylguanidine myocardial scintigraphy with early images alone is useful for the differential diagnosis of dementia with Lewy bodies.
    Manabe Y; Inui Y; Toyama H; Kosaka K
    Psychiatry Res Neuroimaging; 2017 Mar; 261():75-79. PubMed ID: 28152401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease.
    Suzuki M; Kurita A; Hashimoto M; Fukumitsu N; Abo M; Ito Y; Urashima M; Inoue K
    J Neurol Sci; 2006 Jan; 240(1-2):15-9. PubMed ID: 16199056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early diagnosis of Lewy body disease in patients with late-onset psychiatric disorders using clinical history of rapid eye movement sleep behavior disorder and [
    Fujishiro H; Okuda M; Iwamoto K; Miyata S; Torii Y; Iritani S; Ozaki N
    Psychiatry Clin Neurosci; 2018 Jun; 72(6):423-434. PubMed ID: 29536584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
    Orimo S
    Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study.
    Tiraboschi P; Corso A; Guerra UP; Nobili F; Piccardo A; Calcagni ML; Volterrani D; Cecchin D; Tettamanti M; Antelmi L; Vidale S; Sacco L; Merello M; Stefanini S; Micheli A; Vai P; Capitanio S; Gabanelli SV; Riva R; Pinto P; Biffi AM; Muscio C;
    Ann Neurol; 2016 Sep; 80(3):368-78. PubMed ID: 27398636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease.
    Shimizu S; Hirao K; Kanetaka H; Namioka N; Hatanaka H; Hirose D; Fukasawa R; Umahara T; Sakurai H; Hanyu H
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):184-192. PubMed ID: 26233438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders: it can be a specific marker for Lewy body disease.
    Taki J; Yoshita M; Yamada M; Tonami N
    Ann Nucl Med; 2004 Sep; 18(6):453-61. PubMed ID: 15515743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic value of cardiac 123I-metaiodobenzylguanidine (123I-MIBG) scintigraphy in Lewy body disorders].
    Escamilla-Sevilla F; Pérez-Navarro MJ; Muñoz-Pasadas M; Ortega-Léon T; Gallego-Peinado M; Cabello-García D; Gómez Río M; Ortega-Moreno A; Carnero-Pardo C; Rebollo-Aguirre AC; Mínguez-Castellanos A
    Neurologia; 2009 Apr; 24(3):170-6. PubMed ID: 19418293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with Lewy bodies.
    Kashihara K; Ohno M; Kawada S; Okumura Y
    J Nucl Med; 2006 Jul; 47(7):1099-101. PubMed ID: 16818943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in innervation imaging using iodine-123-metaiodobenzylguanidine scintigraphy in Lewy body diseases.
    Treglia G; Cason E; Gabellini A; Giordano A; Fagioli G
    Neurol Sci; 2010 Aug; 31(4):417-22. PubMed ID: 20221656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (123)I-MIBG myocardial scintigraphy and neurocirculatory abnormalities in patients with dementia with Lewy bodies and Alzheimer's disease.
    Kim JS; Park HE; Oh YS; Song IU; Yang DW; Park JW; Lee KS
    J Neurol Sci; 2015 Oct; 357(1-2):173-7. PubMed ID: 26208800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic markers for diagnosing dementia with Lewy bodies: CSF and MIBG cardiac scintigraphy study.
    Wada-Isoe K; Kitayama M; Nakaso K; Nakashima K
    J Neurol Sci; 2007 Sep; 260(1-2):33-7. PubMed ID: 17459416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced cardiac
    Miyamoto T; Miyamoto M
    Brain Commun; 2024; 6(3):fcae148. PubMed ID: 38725707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease.
    Hanyu H; Shimizu S; Hirao K; Kanetaka H; Iwamoto T; Chikamori T; Usui Y; Yamashina A; Koizumi K; Abe K
    Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):248-53. PubMed ID: 16328506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (123)I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in α-synucleinopathies.
    Orimo S; Yogo M; Nakamura T; Suzuki M; Watanabe H
    Ageing Res Rev; 2016 Sep; 30():122-33. PubMed ID: 26835846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial (123)I-MIBG scintigraphy for differentiation of Lewy bodies disease from FTD.
    Novellino F; Bagnato A; Salsone M; Cascini GL; Nicoletti G; Arabia G; Pugliese P; Morelli M; Paglionico S; Cipullo S; Manna I; De Marco EV; Condino F; Chiriaco C; Morgante L; Zappia M; Quattrone A
    Neurobiol Aging; 2010 Nov; 31(11):1903-11. PubMed ID: 19135762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.